Biopapro Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 20-12-2024
- Paid Up Capital ₹ 1.00 M
as on 20-12-2024
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 61.41%
(FY 2023)
- Profit -12.21%
(FY 2023)
- Ebitda -194.56%
(FY 2023)
- Net Worth 47.92%
(FY 2023)
- Total Assets 19.18%
(FY 2023)
About Biopapro
The Company is engaged in the Home & Lifestyle Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Yash Chandan and Nikunj Bhansali serve as directors at the Company.
- CIN/LLPIN
U37100MH2020PTC335814
- Company No.
335814
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jan 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Biopapro Private Limited offer?
Biopapro Private Limited offers a wide range of products and services, including Dinnerware and Serving Utensils, Serving Trays, Spoons, Table Knife and Cutlery, Table Fork, Disposable Cutlery and Crockery, Disposable Bowl, Disposable Cutlery, Spoon, Drinking Straws, Disposable Plate.
Who are the key members and board of directors at Biopapro?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yash Chandan  | Director | 10-Jan-2020 | Current |
| Nikunj Bhansali | Director | 10-Jan-2020 | Current |
Financial Performance of Biopapro.
Biopapro Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 61.41% increase. The company also saw a substantial fall in profitability, with a 12.21% decrease in profit. The company's net worth Soared by an impressive increase of 47.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biopapro?
Unlock access to Biopapro's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Biopapro Cutleries Private LimitedActive 4 years 10 monthsYash Chandan and Nikunj Bhansali are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biopapro?
Unlock and access historical data on people associated with Biopapro, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biopapro, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biopapro's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
